Basics of Compounding: Basics of Compounding with Inorganic Salts
Download in electronic PDF format for $75
Abstract: Pharmacists involved in compounding must consider a number of factors when determining the actual quantity of an active ingredient to use for a compounded prescription. Many drug substances do not consist of 100% drug or chemical, and adjustments must be made to obtain the required amount of active drug (active pharmaceutical ingredient). This is true with inorganic salts, the topic of this article, along with other factors related to physical and chemical properties of the salts that must also be considered.
Related Keywords:
inorganic salts, active pharmaceutical ingredient, powders, compatibility, incompatibility, solubility
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Basics of Compounding: Basics of Compounding with Inorganic Salts
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 146-153
|
Basics of Compounding: Basics of Compounding with Organic Salts
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 322-326
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
The Basics of Compounding Powders and Granules
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 36-39
|
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 56-61
|
Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
|
May/Jun 2004
Pg. 206-209
|
Compatibility of Active Pharmaceutical Ingredients in Cleoderm™: A Comprehensive Study for Enhanced Topical Dermatological Treatments
Marianni Bruna, Mansourian Mercedeh, Koulouridas Savvas, Polonini Hudson
|
Sep/Oct 2024
Pg. 413-422
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 474-481
|
Navigating the Direct Importation of Active Pharmaceutical Ingredients: Compliance Considerations for Compounding Pharmacies
Byars Bradley S, Howard Brad
|
Jan/Feb 2025
Pg. 6-13
|
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Geiger Christine M, Sorenson Bridget, Whaley Paul
|
Sep/Oct 2015
Pg. 420-427
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 118-126
|
Hank's Balanced Salt Solution (Stock Solution)
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 160
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Basics of Sterile Compounding: Manipulating Peptides and Proteins
Akers Michael J
|
May/Jun 2017
Pg. 223-228
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 1
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 328-331
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 64-68
|
Return to Top |